United Health Products Retains IQVIA to Conduct U.S. Market Commercialization Study of HemoStyp® in Support of Société Gé...
April 24 2019 - 8:00AM
United Health Products, Inc. (OTC: UEEC), (“UHP” or “the company”),
manufacturer and marketer of HemoStyp®, a patented hemostatic gauze
for the healthcare and wound care sectors, today announced that it
had retained IQVIA Inc. to conduct a U.S. market commercialization
study for HemoStyp. The primary purpose of the study will be to
assist the company and Société Générale in its previously announced
Review of Strategic Alternatives
(https://www.unitedhealthproductsinc.com/press-releases/2018/11/28/united-health-products-united-health-engages-socit-gnrale-to-undertake-strategic-review).
In addition, IQVIA will perform qualitative primary market
research, and do medical device supply audits using its proprietary
databases. IQVIA’s work is expected to be completed in the near
future.
About IQVIA
IQVIA, a publicly traded company whose stock is listed on the
NYSE (IQV), is a leading global provider of advanced analytics,
technology solutions and contract research services to the life
sciences industry. IQVIA applies human data science — leveraging
the analytic rigor and clarity of data science to the
ever-expanding scope of human science — to enable companies to
reimagine and develop new approaches to clinical development and
commercialization, speed innovation and accelerate improvements in
healthcare outcomes. Powered by the IQVIA CORE™, IQVIA delivers
unique and actionable insights at the intersection of large-scale
analytics, transformative technology and extensive domain
expertise, as well as execution capabilities. With more than 58,000
employees, IQVIA conducts operations in more than 100 countries.
https://www.iqvia.com/
About United Health Products
United Health Products develops, manufactures, and markets
patented hemostatic gauze for the healthcare and wound care
sectors. The product, HemoStyp, is derived from regenerated
oxidized cellulose. HemoStyp is an all-natural product designed to
absorb exudate/drainage from wounds to help control bleeding. UHP
is focused on identifying new markets and applications for its
products and expanding its current markets. UHP currently sells a
suite of hemostatic products to the dental, veterinary and retail
markets.
For more on United Health Products, Inc. visit:
www.unitedhealthproductsinc.com.
Safe Harbor Statement
Safe Harbor Statement under the Private Securities Litigation
Reform Act of 1995: This news release may contain forward-looking
information within the meaning of Section 27A of the Securities Act
of 1933, as amended, and Section 21E of the Securities Exchange Act
of 1934, as amended, including statements that include the words
"believes," "expects," "anticipates" or similar expressions. Such
forward-looking statements involve known and unknown risks,
uncertainties and other factors that may cause the actual results,
performance or achievements of the Company to differ materially
from those expressed or implied by such forward-looking
statements.
Company Contact:United Health Products, Inc.877-358-3444
IR Contact:PAN Consultants Ltd.Philippe
Niemetz212-344-6464p.niemetz@panconsultants.com
IQVIA (NYSE:IQV)
Historical Stock Chart
From Sep 2024 to Oct 2024
IQVIA (NYSE:IQV)
Historical Stock Chart
From Oct 2023 to Oct 2024